22157.jpg
Global Retinal Surgery Devices Market Analysis Report 2022: A $3.7 Billion Market by 2027 - Consistent Efforts by Healthcare Organizations to Fuel the Market
September 26, 2022 08:18 ET | Research and Markets
Dublin, Sept. 26, 2022 (GLOBE NEWSWIRE) -- The "Global Retinal Surgery Devices Market (By Device Segment, Application, Regional Analysis), Impact of COVID-19, Company Profiles, Major Deals, Strategy...
Global Nonmydriatic Handheld Fundus Cameras Market to Reach $192.6 Million by 2026
September 09, 2022 04:13 ET | Research and Markets
Dublin, Sept. 09, 2022 (GLOBE NEWSWIRE) -- The "Nonmydriatic Handheld Fundus Cameras - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.Global...
22157.jpg
Outlook on the Ophthalmoscopes Global Market to 2027 - Rise in Eye Disorder Prevalence & Surgical Procedures is Driving Growth
July 07, 2022 05:03 ET | Research and Markets
Dublin, July 07, 2022 (GLOBE NEWSWIRE) -- The "Ophthalmoscopes Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. Ophthalmoscope...
22157.jpg
Global Ophthalmics Partnering Deal Terms and Agreement 2014-2022: Headline, Upfront and Royalty Terms by Stage of Development
June 14, 2022 04:18 ET | Research and Markets
Dublin, June 14, 2022 (GLOBE NEWSWIRE) -- The "Global Ophthalmics Partnering 2014-2022: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering. The Global...
Insights on the Vision Care Global Market to 2027 - by Product Type, Distribution Channel and Region
April 21, 2022 08:13 ET | Research and Markets
Dublin, April 21, 2022 (GLOBE NEWSWIRE) -- The "Vision Care Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's...
ONL logo.jpg
ONL Therapeutics Appoints Sushanta Mallick as Chief Development Officer
February 09, 2022 07:00 ET | ONL Therapeutics
ANN ARBOR, Mich., Feb. 09, 2022 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
ONL logo.jpg
ONL Therapeutics Closes 2nd Tranche of $46.9 Million Series B Financing Upon Achieving ONL1204 Development Milestones
January 13, 2022 07:00 ET | ONL Therapeutics
– Lead candidate ONL1204 Ophthalmic Solution has advanced into chronic indications of open-angle glaucoma (OAG) and geographic atrophy (GA) associated with age-related macular degeneration (AMD) – –...
22157.jpg
Global Nonmydriatic Handheld Fundus Cameras Market Report 2021: Market to Reach $192.6 Million by 2026 - Fundus Camera Sales Hit by the Pandemic, Poised for Strong Revival
December 06, 2021 05:38 ET | Research and Markets
Dublin, Dec. 06, 2021 (GLOBE NEWSWIRE) -- The "Nonmydriatic Handheld Fundus Cameras - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global...
22157.jpg
Global Vitrectomy Devices Market (2021 to 2026) - Size, Share & Trends Analysis Report
November 08, 2021 06:48 ET | Research and Markets
Dublin, Nov. 08, 2021 (GLOBE NEWSWIRE) -- The "Vitrectomy Devices Market Size, Share & Trends Analysis Report By Product, By Application (Diabetic Retinopathy, Retinal Detachment), By End-use...
22157.jpg
Global Retinal Surgery Device Market (2021 to 2027) - Featuring Topcon, Alcon and Carl Zeiss Among Others
October 25, 2021 04:33 ET | Research and Markets
Dublin, Oct. 25, 2021 (GLOBE NEWSWIRE) -- The "Retinal Surgery Device Market, Global Forecast, Impact of COVID-19, Industry Trends, by Product, Growth, Opportunity Company Analysis" report has been...